Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysophosphatidic acid (LPA) is a simple, bioactive phospholipid that acts as a potent intercellular signaling molecule. It stimulates cell proliferation, survival, migration, and differentiation in multiple cell types. LPA plays roles in development, angiogenesis, wound healing, immune responses, and pathological conditions such as cancer progression and neuropathic pain. LPA exerts its effects mainly through binding to specific G protein-coupled receptors (GPCRs) known as LPARs. Aberrant regulation or overproduction/signaling through the autotaxin-LPA axis has been implicated in several diseases, making it a target for therapeutic intervention.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysophosphatidic Acid (LPA).